Novartis Investigative Site

Nashua, New Hampshire 03060

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Chronic Heart Failure With Reduced Ejection Fraction. Clinical Trial
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Nashua, NH
Click here to add this to my saved trials
Atherosclerosis Clinical Trial
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Nashua, NH
Click here to add this to my saved trials